- $2.65m
- $1.15m
- $24.16m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.7 | 41.9 | 44.5 | 35.4 | 24.2 |
Cost of Revenue | |||||
Gross Profit | 14.5 | 26.4 | 30 | 22.3 | 15 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 71.4 | 30.4 | 69.3 | 106 | 46.5 |
Operating Profit | -47.8 | 11.4 | -24.8 | -70.4 | -22.3 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -47.8 | 11.3 | -24.3 | -70.1 | -22.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -45.4 | 12.7 | -23.4 | -70.1 | -22.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -50.4 | 12.6 | -23.4 | -70.1 | -22.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -50.4 | 12.2 | -25.9 | -74.1 | -26.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -57.3 | -6.55 | -18.5 | -15.9 | -6.88 |